Company intelligence / Profile preview
Zhejiang Xinlifi Biotechnology
- Ownership
- Private
- Development stage
- Other
Overview
Zhejiang Xinlifi Biotechnology is a Chinese biopharmaceutical company specializing in the development of mRNA-based therapeutics and vaccines. Founded in 2021 and headquartered in Hangzhou, the company leverages a proprietary lipid nanoparticle (LNP) delivery platform to address infectious diseases, oncology, and rare genetic disorders. Their current pipeline includes mRNA vaccine candidates for COVID-19, respiratory syncytial virus (RSV), and seasonal influenza. Xinlifi focuses on optimizing mRNA stability and delivery efficiency to create next-generation precision medicines. The company is actively expanding its manufacturing capabilities to support clinical-scale production of mRNA-LNP formulations.
- Therapeutic areas
- OncologyRare DiseasesInfectious Diseases
- Modalities
- mRNA-based drugsLipid nanoparticle delivery therapyVaccine
- Industry
- Biotech
Drug pipeline
1 assetBeyond the preview
Go deeper on Zhejiang Xinlifi Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Zhejiang Xinlifi Biotechnology.